Drug · DIN 01962817
ZOLOFT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 22, 2023; first marketed December 31, 1992.
- Drug Identification Number (DIN)
- 01962817
- Company (DIN owner)
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Sertraline N06AB06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SERTRALINE (SERTRALINE HYDROCHLORIDE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 22, 2023: NOC 31470New Drug Submission (NDS) · Administrative: Change in Product Ownership
- May 15, 2020: NOC 23612New Drug Submission (NDS) · Administrative: Change in Product Ownership
Other DINs named ZOLOFT
- DIN 01962779 · Marketed
- DIN 02132702 · Marketed